Guo Guangchang of Fosun International: The approval of the C...

Guo Guangchang of Fosun International: The approval of the COVID-19 mRNA vaccine Fobitac is progressing normally, and the procedures are fair and transparent. The CDE (Drug Evaluation Center of the National Drug Administration) and the Drug Administration gave Fosun great support.

Fosun Pharmaceutical's A shares and Hong Kong stocks rose in a straight line during the intraday period, all rising 5% at one point.

Fosun says China's review of BioNtech shots taken seriously.

Shares of Shanghai Fosun Climb 4.58% in Shanghai at the Morning Close.

Shanghai Fosun Relaxation 6.72% at The Morning Close in HongKong.